Home Newsfeeds Baird Downgrades Evoqua Water Techs to Neutral, Maintains $49 Price Target

Baird Downgrades Evoqua Water Techs to Neutral, Maintains $49 Price Target

Baird analyst Michael Halloran downgrades Evoqua Water Techs (NYSE:AQUA) from Outperform to Neutral and maintains $49 price target.

byBenzinga Newsdesk

February 1, 2023

1 minute read

Baird analyst Michael Halloran downgrades Evoqua Water Techs (NYSE:AQUA) from Outperform to Neutral and maintains $49 price target.

HighPeak Energy Stock Is Getting Drilled: What’s Going On?

By Adam Eckert

July 18, 4:27 PM

HighPeak Energy Inc (NASDAQ: HPK) shares are trading lower in Tuesday's after-hours session after the company

HPK

Bitcoin Tops $44,000 Following Jobs Data; Osmosis Emerges As Top Gainer

By Avi Kapoor

January 5, 10:35 AM

Bitcoin (CRYPTO: BTC) moved higher, with the cryptocurrency prices trading above the key $44,000 level on Friday. Ethereum (CRYPTO: ETH) also edged higher, trading above the key $2,200 mark this morning.

$BONK

Stephens & Co. Maintains Overweight on TriCo, Lowers Price Target to $56

By Benzinga Newsdesk

January 31, 10:21 AM

Stephens & Co. analyst Andrew Terrell maintains TriCo (NASDAQ:TCBK) with a Overweight and lowers the price target from $57 to $56.

TCBK

Cognition Therapeutics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/783,943 Titled “Isoindoline Compositions And Methods For Treating Neurodegenerative Disease (Including Alzheimer’s Disease)”.

By Happy Mohamed

February 3, 3:07 PM

https://patentcenter.uspto.gov/#!/applications/16783943/ifw/docs

CGTX

Baird Downgrades Evoqua Water Techs to Neutral, Maintains $49 Price Target

Related Posts

HighPeak Energy Stock Is Getting Drilled: What’s Going On?

Bitcoin Tops $44,000 Following Jobs Data; Osmosis Emerges As Top Gainer

Stephens & Co. Maintains Overweight on TriCo, Lowers Price Target to $56

Cognition Therapeutics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/783,943 Titled “Isoindoline Compositions And Methods For Treating Neurodegenerative Disease (Including Alzheimer’s Disease)”.